COR.NYSECencora, INC

Form 4: Cencora CEO Robert Mauch Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Cencora's CEO, Robert P. Mauch, exercised stock options and sold shares of common stock on March 3, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 3, 2025, Robert P. Mauch, the President & CEO of Cencora, Inc. [COR], engaged in transactions involving the company's common stock.
  • Mauch exercised non-qualified stock options to acquire 3,226 shares at an exercise price of $86.09.
  • Simultaneously, Mauch sold 1,744 shares at $255 and 3,226 shares at $255.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 15, 2024.
  • Following these transactions, Mauch directly owns 51,070 shares of Cencora common stock and holds options for 41,928 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to sell shares over a period of time, avoiding concerns about trading on material non-public information. These transactions are closely watched by investors for insights into management's perspective on the company's value.

Comparison to Industry Standards

  • Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
  • Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock holdings in a compliant manner.
  • Comparing Mauch's stock ownership and option holdings to those of CEOs at similar-sized pharmaceutical distribution companies (e.g., McKesson, Cardinal Health) could provide a benchmark for assessing the magnitude of his stake.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
  • The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
11/15/24Date of adoption of Rule 10b5-1 trading plan.
03/03/2025Date of stock option exercise and stock sales.
03/04/2025Date of Form 4 filing.
11/13/2026Expiration date of the non-qualified stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.